Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1656 1693 1754
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17849327 | Methods and Compositions for Producing a Heterologous Antiviral Compound in a Host Cell | Final Rejection | The Regents of the University of California |
| 18017426 | ALANINE RACEMASE SINGLE DELETION AND TRANSCOMPLEMENTATION | Final Rejection | BASF SE |
| 19264681 | PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION | Final Rejection | Clara Foods Co. |
| 18452884 | CYCLIC LIPOPEPTIDE-PRODUCING MICROBIAL STRAIN AND METHOD FOR PRODUCING CYCLIC LIPOPEPTIDE | Non-Final OA | KANEKA CORPORATION |
| 18247616 | A DNA Assembly Mix And Method Of Uses Thereof | Non-Final OA | National University of Singapore |
| 17436338 | NON-VIRAL MODIFICATION OF MESENCHYMAL STEM CELLS | Non-Final OA | NATIONAL UNIVERSITY OF SINGAPORE |
| 17938752 | De novo designed protein homodimers containing tunable symmetric pockets | Non-Final OA | University of Washington |
| 17556708 | SYSTEMS AND METHODS FOR METABOLIC ENGINEERING | Final Rejection | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 17021319 | NANOLITER-SCALE SAMPLE PROCESSING AND MASS SPECTROMETRY ACQUISITION METHOD FOR SINGLE CELL PROTEOMICS | Final Rejection | BATTELLE MEMORIAL INSTITUTE |
| 18036695 | MICROBIAL PRODUCTION OF TITIN FIBERS WITH EXCEPTIONAL MECHANICAL PERFORMANCE | Non-Final OA | Washington University |
| 18707400 | 3D-PRINTING ENGINEERED LIVING MATERIALS | Non-Final OA | The Trustees of Princeton University |
| 18756409 | A PROCESS FOR MANUFACTURING A POTENTIATING PROTEIN COMPOSITION WITH INCREASED EFFICIENCY AND LONGEVITY AND USES THEREOF | Non-Final OA | 14787285 Canada Inc. dba Nuria Scientific |
| 18255869 | METHODS AND COMPOSITIONS FOR INHIBITING EXCESS NUCLEIC ACID PRECIPITATION | Non-Final OA | PFIZER INC. |
| 18020843 | REAL-TIME CELLULAR THERMAL SHIFT ASSAY (RT-CETSA) FOR RESEARCH AND DRUG DISCOVERY | Non-Final OA | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 17924204 | THERAPEUTIC OR PREVENTIVE AGENT FOR INFECTIOUS DISEASE | Final Rejection | NIPPON MEDICAL SCHOOL FOUNDATION |
| 18031301 | PROTEIN HAVING FERMENTED MILK VISCOSITY IMPROVING EFFECT, FERMENTED MILK USING THE SAME AND METHOD FOR PRODUCING THE SAME | Non-Final OA | MEIJI CO., LTD. |
| 17908761 | MODIFIED TRANSGLUTAMINASE | Final Rejection | Amano Enzyme Inc. |
| 18275255 | CELL CULTURE METHODS | Non-Final OA | DR. REDDY’S LABORATORIES LIMITED |
| 18280403 | GENE FOR EFFICIENTLY EXPRESSING HYALURONIC ACID HYDROLASE AND EXPRESSION METHOD THEREOF | Non-Final OA | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED |
| 16627227 | AAV VECTOR COLUMN PURIFICATION METHODS | Non-Final OA | Spark Therapeutics, Inc. |
| 17416814 | URINE STABILIZATION | Final Rejection | QIAGEN GmbH |
| 18254859 | RECOMBINANT MICROORGANISM HAVING IMPROVED ABILITY TO PRODUCE RECOMBINANT SILK PROTEIN AND METHOD FOR PRODUCING HIGH-MOLECULAR-WEIGHT RECOMBINANT SILK PROTEIN BY USING SAME | Final Rejection | MEDICOSBIOTECH, INC |
| 18176546 | Compositions and Methods for Modulating Factor IX Function | Final Rejection | The Children's Hospital of Philadelphia |
| 18131968 | BIOSENSING ELEMENT BASED ON SPECIFIC BINDING OF CBM AND CELLULOSE | Non-Final OA | BIOLOGY INSTITUTE OF SHANDONG ACADEMY OF SCIENCES |
| 18296454 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES | Final Rejection | SHANGHAI HEP PHARMACEUTICAL CO., LTD. |
| 18174319 | Preparation Method And Usage Method For Cartilage Tissue Recovery Collagen | Non-Final OA | Cellontech Co., Ltd. |
| 18020429 | METHOD FOR THE EFFICIENT EXPRESSION AND PURIFICATION AND APPLICATION OF A RECOMBINANT FUSION PROTEIN OF MANNASE AND HOMOLOGUES THEREOF AND GLP-1 | Non-Final OA | ANHUI NEW SIMON BIOTECH CO., LTD. |
| 18002806 | Compositions and Methods for Treating Hemorrhagic Shock | Non-Final OA | VirTech Bio, Inc |
| 17761929 | SYSTEMS AND METHODS FOR PROTEIN EXPRESSION | Non-Final OA | ExcepGen Inc |
| 17428581 | Generation Of Water-Soluble Cannabinoids Utilizing Protein Cannabinoid-Carriers | Non-Final OA | Trait Biosciences, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy